Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16870006 | 1.00 | CTSL (0.51) | CTSL | |
| SCHEMBL16862485 | 0.93 | CTSL (0.54) | CTSL | |
| SCHEMBL21627096 | 0.93 | CTSL (0.54) | CTSL | |
| Hydrochloric Acid SCHEMBL16862473 | 0.92 | CTSL (0.53) | CTSL | |
| SCHEMBL20794744 | 0.90 | CTSL (0.49) | CTSL | |
| SCHEMBL24012348 | 0.89 | PSMB8 (0.53) | CTSL | |
| SCHEMBL16870000 | 0.89 | PSMB8 (0.53) | CTSL | |
| SCHEMBL18840120 | 0.89 | CTSL (0.52) | CTSL | |
| SCHEMBL18840126 | 0.88 | PSMB1 (0.51) | — | |
| Trifluoroacetic Acid SCHEMBL16862455 | 0.88 | CTSL (0.51) | CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3087093-B1 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2021-11-10 | — | — | EP | disclosed |
| US-10696716-B2 | Pharmaceutically relevant aromatic-cationic peptides | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-06-30 | — | — | US | disclosed |
| US-20200024308-A1 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200024308-A1 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | ADM2, VIP, ANPEP | CTSL 212/4885 |
| US-10696716-B2 | Pharmaceutically relevant aromatic-cationic peptides | ADM2, VIP, ANPEP | CTSL 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.